Compare SPRY & CIVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SPRY | CIVB |
|---|---|---|
| Founded | 2015 | 1884 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.5M | 571.6M |
| IPO Year | 2020 | 2012 |
| Metric | SPRY | CIVB |
|---|---|---|
| Price | $5.90 | $27.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $40.00 | $26.60 |
| AVG Volume (30 Days) | ★ 1.7M | 134.8K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.90% |
| EPS Growth | N/A | ★ 31.34 |
| EPS | N/A | ★ 1.41 |
| Revenue | ★ $84,278,000.00 | $19,023,000.00 |
| Revenue This Year | $87.40 | $14.88 |
| Revenue Next Year | $81.64 | $5.99 |
| P/E Ratio | ★ N/A | $19.45 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.91 | $19.84 |
| 52 Week High | $13.15 | $29.97 |
| Indicator | SPRY | CIVB |
|---|---|---|
| Relative Strength Index (RSI) | 47.54 | 40.69 |
| Support Level | $4.96 | $27.00 |
| Resistance Level | $6.58 | $29.31 |
| Average True Range (ATR) | 0.38 | 0.55 |
| MACD | 0.09 | -0.12 |
| Stochastic Oscillator | 61.08 | 24.26 |
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.